Pfizer CentreOne Capacity Update May 2024: Fill/Finish

As an award-winning global CDMO, Pfizer CentreOne uses Pfizer’s extensive scientific and technical expertise to manufacture sterile injectable medicines for pharmaceutical and biotech companies like yours. Around the world, our Pfizer scientific and manufacturing experts leverage their decades of experience supporting a broad range of complex therapeutics – including ADCs, vaccines, mAbs, and gene and cell therapies – alongside our specialized facilities to unlock the potential of your SI drug substance (liquid or lyophilized) and product (PFS, vials, cartridges). As an experienced partner with broad capabilities, we can help you skillfully maneuver through complexities, keeping pace with both scientific advancements and regulatory requirements.

In this session Senior Business Development Manager, Christine Rodi, highlights Pfizer CentreOne’s overall sterile injectable drug substance capabilities, with a focus on their ability to help meet your complex sterile injectable needs. From liquid and lyo to pre-filled syringes, vials, and cartridges – helping you unlock the potential of your sterile injectable for your patients – because time is life.